Anne Vanlent - Net Worth and Insider Trading
Anne Vanlent Net Worth
The estimated net worth of Anne Vanlent is at least $248,119 dollars as of 2024-11-10. Anne Vanlent is the Director of Integra Lifesciences Holdings Corp and owns about 6,956 shares of Integra Lifesciences Holdings Corp (IART) stock worth over $172,509. Anne Vanlent is also the Director of Trevi Therapeutics Inc and owns about 25,983 shares of Trevi Therapeutics Inc (TRVI) stock worth over $75,611. Details can be seen in Anne Vanlent's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anne Vanlent has not made any transactions after 2019-05-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Anne Vanlent
Anne Vanlent Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anne Vanlent owns 9 companies in total, including Trevi Therapeutics Inc (TRVI) , Applied Genetic Technologies Corp (AGTC) , and Vaxart Inc (VXRT) among others .
Click here to see the complete history of Anne Vanlent’s form 4 insider trades.
Insider Ownership Summary of Anne Vanlent
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TRVI | Trevi Therapeutics Inc | 2019-05-09 | director |
| AGTC | Applied Genetic Technologies Corp | 2016-08-17 | director |
| VXRT | Vaxart Inc | 2013-05-01 | director |
 | | 2017-12-11 | director |
| | 2016-12-22 | director |
| | 2016-11-29 | director |
| | 2013-07-24 | director |
| | 2011-01-13 | director |
| | 2023-01-01 | director |
Anne Vanlent Latest Holdings Summary
Anne Vanlent currently owns a total of 2 stocks. Among these stocks, Anne Vanlent owns 6,956 shares of Integra Lifesciences Holdings Corp (IART) as of January 13, 2011, with a value of $172,509 and a weighting of 69.53%. Anne Vanlent also owns 25,983 shares of Trevi Therapeutics Inc (TRVI) as of May 9, 2019, with a value of $75,611 and a weighting of 30.47%.
Latest Holdings of Anne Vanlent
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IART | Integra Lifesciences Holdings Corp | 2011-01-13 | 6,956 | 24.80 | 172,509 |
| TRVI | Trevi Therapeutics Inc | 2019-05-09 | 25,983 | 2.91 | 75,611 |
Holding Weightings of Anne Vanlent
Anne Vanlent Form 4 Trading Tracker
According to the SEC Form 4 filings, Anne Vanlent has made a total of 0 transactions in Integra Lifesciences Holdings Corp (IART) over the past 5 years. The most-recent trade in Integra Lifesciences Holdings Corp is the sale of 10,540 shares on January 13, 2011, which brought Anne Vanlent around $250,272.
According to the SEC Form 4 filings, Anne Vanlent has made a total of 0 transactions in Trevi Therapeutics Inc (TRVI) over the past 5 years. The most-recent trade in Trevi Therapeutics Inc is the acquisition of 5,000 shares on May 9, 2019, which cost Anne Vanlent around $50,000.
Insider Trading History of Anne Vanlent
- 1
Anne Vanlent Trading Performance
GuruFocus tracks the stock performance after each of Anne Vanlent's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anne Vanlent is -40.12%. GuruFocus also compares Anne Vanlent's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anne Vanlent within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Anne Vanlent's insider trading performs compared to the benchmark.
Performance of Anne Vanlent
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.69 | | | | | |
| Relative Return to S&P 500(%) | 14.6 | | | | | |
Anne Vanlent Ownership Network
Ownership Network List of Anne Vanlent
Ownership Network Relation of Anne Vanlent
Anne Vanlent Owned Company Details
What does Trevi Therapeutics Inc do?
Who are the key executives at Trevi Therapeutics Inc?
Anne Vanlent is the director of Trevi Therapeutics Inc. Other key executives at Trevi Therapeutics Inc include director & 10 percent owner & See Remarks Jennifer L Good , director & 10 percent owner David P Meeker , and 10 percent owner & Chief Medical Officer Thomas Sciascia .
Trevi Therapeutics Inc (TRVI) Insider Trades Summary
Over the past 18 months, Anne Vanlent made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 8,387 shares made by Lisa Delfini , a net sale of 90,795 shares made by Jennifer L Good , and a net sale of 101,369 shares made by Thomas Sciascia .
In summary, during the past 3 months, insiders sold 113,736 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 113,736 shares. During the past 18 months, 205,106 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 205,106 shares.
Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Trevi Therapeutics Inc Insider Transactions
Anne Vanlent Mailing Address
Above is the net worth, insider trading, and ownership report for Anne Vanlent. You might contact Anne Vanlent via mailing address: C/o Barrier Therapeutics, Inc., 600 College Road East, Suite 3200, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
